Trial Profile
Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2021
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Clopidogrel; Lansoprazole
- Indications Haemorrhage; Myocardial infarction; Stroke; Thrombosis
- Focus Therapeutic Use
- Acronyms PRAGUE-18
- 01 Sep 2020 Results of a post hoc analysis of the multicenter randomized PRAGUE-18 study, presented at the ESC Congress 2020 - Annual Congress of the European Society of Cardiology
- 01 Sep 2020 Results presented at the ESC Congress 2020 - Annual Congress of the European Society of Cardiology
- 01 Aug 2020 Results evaluating CYP2C19 and CYP3A4 activity and ADP-induced platelet reactivity in prasugrel or ticagrelor treated STEMI patients, published in the Xenobiotica